Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Market Access

Mapping the Vertical Integration of Insurers, PBMs, GPOs, Specialty Pharmacies, and Healthcare Services: DCI’s 2026 Update

 April 14, 2026

Drug Channels

It’s time for Drug Channels Institute’s (DCI) annual update of vertical integration among insurers, PBMs, specialty pharmacies, and healthcare services within U.S.

Market AccessRead full story

Post navigation

Novo Nordisk partners OpenAI on R&D “transformation” →
← FDA renews criticism of trial sponsors over transparency

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com